We are pleased to announce Dr. Yan Zhi has joined Charles River as Director of Scientific Services.
Dr. Zhi joins us from Fujifilm Diosynth Biotechnologies, where she was most recently Director of Program Design, supporting cGMP manufacturing programs of gene therapy products while providing scientific and regulatory support to clients to address and resolve challenges. She comes to us with strong experience and regulatory knowledge in our key areas and a deep background in CRO-related services and regulatory requirements for gene therapies. Dr. Zhi will be providing scientific leadership to the Biologics Testing Solutions business of Charles River, and will use her expertise to help identify opportunities for expansion of science and technology for the ever-evolving gene and cell therapy industry, along with other focus areas such as pathogen safety and cell and viral bank manufacturing.
Dr. Zhi's experience will broaden our knowledge and help us continue to lead with science as we help you to achieve your development goals.